Annamaria Ferrero

Waist-to-hip ratio measured with computed tomography as a predictor of surgical outcomes in minimally invasive procedures for early-stage endometrial cancer

Symptom Monitoring in Ovarian Cancer Patients Treated with PARP Inhibitors: Agreement Between Physician- and Patient-Reported Toxicities Using PRO-CTCAE.

Regional Audit and Feedback Intervention to Improve Quality of Care in Ovarian Cancer Treatment: The Easy-Net Experience.

Flowchart for endometrial cancer classification integrating FIGO 2023 staging and ESGO/ESTRO/ESP 2025 risk categories

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).

SUCCOR 10 years: a decade’s perspective on radical hysterectomy outcomes in cervical cancer

Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer.

European training requirements for gynecological oncology: the European Society of Gynaecological Oncology Curriculum.

Comparative Study of Mastectomy Surgical Techniques Followed by Reconstruction: Hydrodissection and Electrical Plasma Surgery.

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

SENECA study: staging endometrial cancer based on molecular classification

New Frontiers in Locally Advanced Cervical Cancer Treatment.

Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review.

Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients

PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review.

Development and clinical application of a tool to identify frailty in elderly patients with gynecological cancers.

Impact of Pregnancy on Breast Cancer Features and Prognosis.

Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients.

PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer Through a Multimodal Patient Journey: Case Reports and Literature Review.

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience.

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer

How challenging could be preoperative and intraoperative diagnosis of endometrial cancer?

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.

Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer